Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Radiation Injuries × Immunotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 30 Melanoma 12 Neoplasm Metastasis 11 Lung Neoplasms 10 Carcinoma, Hepatocellular 10 Neoplasms 8 Esophageal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Colorectal Neoplasms 6 Esophageal Squamous Cell Carcinoma 5 Breast Neoplasms 5 Rectal Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Recurrence 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm, Residual 2 Multiple Myeloma 2 Liver Diseases 2 Hyperthermia 2

Interventions

Radiotherapy 26 Amifostine 11 Cisplatin 10 Paclitaxel 7 Carboplatin 7 Radiotherapy, Intensity-Modulated 5 Etoposide 5 Radiosurgery 4 Donepezil 4 Brachytherapy 4 Bevacizumab 4 Surgical Procedures, Operative 3 Mental Status and Dementia Tests 3 Filgrastim 3 Diet Therapy 3 Blood Specimen Collection 3 sargramostim 2 Radiation 2 Proton Therapy 2 Magnetic Resonance Spectroscopy 2 Low-Level Light Therapy 2 Lithium 2 Hyperbaric Oxygenation 2 Dexamethasone 2 Chemotherapy, Adjuvant 2 Adrenal Cortex Hormones 2 sodium propionate 1 olaparib 1 lithium sulfate 1 ethanethiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07396116 2026-02-12

FUSION-02

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting

Radiation Injuries, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡